Her2 Positive Solid Tumor clinical trials

Explore recruiting her2 positive solid tumor clinical trials.

Recruiting her2 positive solid tumor studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Her2 Positive Solid Tumor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ELVN-002 in Solid Tumors with a HER2 Genetic Alteration

Spain, Italy, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Her2 Positive Solid Tumor trials by city

Her2 Positive Solid Tumor in Toronto Her2 Positive Solid Tumor in Vancouver Her2 Positive Solid Tumor in Montreal Her2 Positive Solid Tumor in Calgary Her2 Positive Solid Tumor in Edmonton Her2 Positive Solid Tumor in Ottawa Her2 Positive Solid Tumor in Winnipeg Her2 Positive Solid Tumor in Quebec City Her2 Positive Solid Tumor in Hamilton Her2 Positive Solid Tumor in Kitchener Her2 Positive Solid Tumor in London Her2 Positive Solid Tumor in Halifax Her2 Positive Solid Tumor in New York Her2 Positive Solid Tumor in Los Angeles Her2 Positive Solid Tumor in Chicago Her2 Positive Solid Tumor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease